Frontlight ResearchEarly access
Hypertrophic cardiomyopathy trials in China
9 of 19 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 4Enrolling by invitationThe Therapeutic Value of Mavacamten in Hypertrophic Cardiomyopathy With Mid-to-Apical Left Ventricular Obstruction
- Where
- Hangzhou
- Age
- 18 years to 75 years
- People
- 132
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07103655 - No phaseNot yet taking people in ChinaGradual Tapering or Discontinuation of Beta-Blockers After Stabilization With Mavacamten Therapy
- Where
- Wenzhou
- Age
- 18 years to 75 years
- People
- 286
- Run by
- First Affiliated Hospital of Wenzhou Medical University
See details and how to joinNCT07815301 - Phase 2Taking peopleAdemetionine in Obstructive Hypertrophic Cardiomyopathy
- Where
- Beijing, Shanghai, Xinjiang
- Age
- 18 years and over
- People
- 44
- Run by
- China National Center for Cardiovascular Diseases
See details and how to joinNCT07367724 - Phase 1/2Taking peopleApplication of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases
- Where
- Beijing
- Age
- 18 years to 85 years
- People
- 30
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT07464132 - No phaseNot yet taking people in ChinaEffect of Henagliflozin on Myocardial Fibrosis in Non-Obstructive HCM: A Randomized, Double-Blind, Placebo-Controlled Trial Using 68Ga/18F-FAPI PET/CMR
- Where
- Shanghai
- Age
- 18 years and over
- People
- 150
- Run by
- Shanghai East Hospital
See details and how to joinNCT07294495 - No phaseTaking peopleREFINE-HCM: Intramyocardial Septal Radiofrequency Ablation for Obstructive Hypertrophic Cardiomyopathy
- Where
- Beijing, Hangzhou
- Age
- 18 years to 80 years
- People
- 124
- Run by
- SuZhou Sinus Medical Technologies Co.,Ltd
See details and how to joinNCT07006493 - Phase 2Taking peopleA Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy
- Where
- Beijing
- Age
- 18 years to 85 years
- People
- 300
- Run by
- Shandong Suncadia Medicine Co., Ltd.
See details and how to joinNCT07021963 - No phaseNot yet taking people in ChinaEarly Identification and Treatment of Rare Cardiomyopathy Cohorts
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 300
- Run by
- RenJi Hospital
See details and how to joinNCT06794710 - No phaseTaking peopleConcomitant Hybrid Versus Catheter Ablation for Atrial Fibrillation With Hypertrophic Cardiomyopathy
- Where
- Beijing
- Age
- 18 years and over
- People
- 66
- Run by
- China National Center for Cardiovascular Diseases
See details and how to joinNCT05610215